Sign in
Taking peopleNo phase

Diagnosis, Treatment, and Outcome Assessment of Septic Cardiomyopathy Using an Integrated Mathematical Model

Key facts

Who runs it
Vilnius University
Where
Lithuania and Poland2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
17 Mar 2024
Expected to end
Mar 2028
Type of study
Observational
Record updated
27 January 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (16)Hide the full registry criteria

Who can take part

  • Age 18 years or older
  • Sepsis according to SEPSIS-3 criteria:
  • Suspected/confirmed infection and
  • SOFA (Sequential Organ Failure Assessment) score ≥ 2 or qSOFA score ≥ 2
  • Septic shock according to SEPSIS-3 criteria:
  • Sepsis is diagnosed and
  • Vasopressor infusion is used to maintain a mean arterial pressure (MAP) ≥ 65 mmHg and
  • Lactate \> 2 mmol/l
  • Cardiovascular support requirement for norepinephrine \> 0.1 mcg/kg/min infusion
  • Signed informed consent form (ICF)

Who cannot take part

  • Has uncompensated cardiovascular disease:
  • Congenital heart disease
  • Heart failure NYHA functional class IV
  • Individuals under 18 years of age
  • Cardiogenic shock
  • Refusal to participate in the study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Septic cardiomyopathy

This trial is currently available in Lithuania and Poland.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to evaluate whether a new integrated mathematical model can improve the accuracy of diagnosing septic cardiomyopathy and predicting clinical outcomes in adult patients with suspected septic cardiomyopathy. The study aims to determine whether the integrated mathematical model enhances diagnostic accuracy and improves the prediction of clinical outcomes in these patients.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Use of an Integrated Mathematical Model for the Diagnosis, Treatment and Outcome Assessment of Septic Cardiomyopathy
Criteria questions
Built from NCT06793020, who can take part
Record updated
27 January 2025